The S&P 500 was on track to recoup about US$1 trillion in market value in a frantic rally on Monday after New York, the biggest U.S. coronavirus hot spot, reported a fall in daily deaths, raising hopes that the pandemic could level-off soon.
Qatar Petroleum will postpone the start of production from its new gas facilities to 2025 due to a delay in the bidding process, but is not downsizing the world's largest liquefied natural gas project despite concerns of a mounting glut, its chief executive told Reuters.
RavnAir Group, the largest regional carrier in Alaska, filed for bankruptcy Sunday and grounded all of its 72 planes as it waits on a decision from U.S. Treasury for government assistance.
Michael Kors owner Capri Holdings Ltd said on Monday it would furlough all its 7,000 employees in North America amid the coronavirus pandemic, as it expects to open its stores only after June 1.
Luckin Coffee Chairman Charles Zhengyao Lu and Chief Executive Jenny Zhiya Qian have handed over shares in the embattled Chinese coffee chain to lenders after a company controlled by Lu's family defaulted on a US$518 margin loan, one of the banks said on Monday.
White House advisers have been discussing the possibility of a coronavirus-related U.S. Treasury bond, President Donald Trump's economic adviser Larry Kudlow told CNBC on Monday.
"Darknet" trading platforms where contraband from drugs to stolen credit cards usually change hands are offering face masks and other coronavirus-related gear in return for bitcoin, researchers said on Monday.
CVS Health Corp , called on by the Trump administration last month to help test Americans for infections from the new coronavirus, said it was launching two offsite testing locations with Abbott Laboratories' faster diagnostic kit and would be able to handle 1,000 tests per day.
SINGAPORE'S largest bank DBS will progressively close 29 DBS/POSB branches islandwide over the course of about one week, in light of stricter safe distancing measures to reduce the community spread of Covid-19.
British drugmaker GlaxoSmithKline Plc will invest US$250 million in Vir Biotechnology Inc and collaborate to develop potential treatments for COVID-19, the disease caused by the new coronavirus, the companies said on Monday.
